Log in
NYSE:VIE

Viela Bio News Headlines

$32.74
+0.67 (+2.09 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$31.25
Now: $32.74
$32.75
50-Day Range
$25.48
MA: $30.44
$35.16
52-Week Range
$19.01
Now: $32.74
$70.66
Volume90,927 shs
Average Volume221,662 shs
Market Capitalization$1.79 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Viela Bio (NYSE VIE) News Headlines Today

Source:
DateHeadline
Viela Bio (NYSE:VIE) Stock Price Up 5.9%Viela Bio (NYSE:VIE) Stock Price Up 5.9%
americanbankingnews.com - October 22 at 8:37 PM
Viela Bio (NYSE:VIE) to Post FY2021 Earnings of ($2.30) Per Share, Wedbush ForecastsViela Bio (NYSE:VIE) to Post FY2021 Earnings of ($2.30) Per Share, Wedbush Forecasts
americanbankingnews.com - October 21 at 12:22 PM
Viela Bio (NYSE:VIE) Trading Up 9.6%Viela Bio (NYSE:VIE) Trading Up 9.6%
americanbankingnews.com - October 16 at 6:43 PM
Viela Bio (NYSE:VIE) Shares Up 11.2%Viela Bio (NYSE:VIE) Shares Up 11.2%
americanbankingnews.com - October 5 at 7:31 PM
Viela Bio (NYSE:VIE) Receives Average Recommendation of "Buy" from BrokeragesViela Bio (NYSE:VIE) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - September 30 at 5:26 AM
Viela Bio Inc (VIE) Investor Presentation - SlideshowViela Bio Inc (VIE) Investor Presentation - Slideshow
seekingalpha.com - September 15 at 3:18 PM
Viela Bio Announces Data Presentations at the 8th Joint ACTRIMS-ECTRIMS Meeting, MS Virtual 2020Viela Bio Announces Data Presentations at the 8th Joint ACTRIMS-ECTRIMS Meeting, MS Virtual 2020
finance.yahoo.com - September 3 at 6:53 PM
Viela Bio, Inc. 2020 Q2 - Results - Earnings Call PresentationViela Bio, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 13 at 4:21 PM
Viela Bio, Inc. (VIE) CEO Bing Yao on Q2 2020 Results - Earnings Call TranscriptViela Bio, Inc. (VIE) CEO Bing Yao on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 7:23 AM
Viela Bio Inc (VIE) Q2 2020 Earnings Call TranscriptViela Bio Inc (VIE) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 13 at 7:22 AM
VIELA BIO EPS beats by $0.32VIELA BIO EPS beats by $0.32
seekingalpha.com - August 12 at 8:39 PM
Viela Bio Reports Second Quarter 2020 Financial Results and Program HighlightsViela Bio Reports Second Quarter 2020 Financial Results and Program Highlights
finance.yahoo.com - August 12 at 8:39 PM
Washington, D.C. Health Care NewsWashington, D.C. Health Care News
bizjournals.com - August 12 at 3:38 PM
Another D.C. firm has quietly gone public. We have the details.Another D.C. firm has quietly gone public. We have the details.
bizjournals.com - August 11 at 4:42 PM
Viela Bio to Webcast Second Quarter 2020 Financial Results and Program Highlights on August 12, 2020Viela Bio to Webcast Second Quarter 2020 Financial Results and Program Highlights on August 12, 2020
finance.yahoo.com - August 5 at 8:14 AM
Viela Bios journey to market with its first drug hasnt been without its bumps. But its forging on.Viela Bio's journey to market with its first drug hasn't been without its bumps. But it's forging on.
www.bizjournals.com - July 23 at 9:13 AM
3 Ultra-High-Growth Biopharma Stocks to Grab Now3 Ultra-High-Growth Biopharma Stocks to Grab Now
www.fool.com - June 19 at 7:47 AM
Viela Bio receives FDA approval for autoimmune treatmentViela Bio receives FDA approval for autoimmune treatment
www.bizjournals.com - June 12 at 2:21 PM
Hedge Funds Cautiously Watching Viela Bio, Inc. (VIE)Hedge Funds Cautiously Watching Viela Bio, Inc. (VIE)
finance.yahoo.com - June 12 at 2:21 PM
FDA approves Vielas rare disease treatment, analysts predict $500 million in salesFDA approves Viela's rare disease treatment, analysts predict $500 million in sales
finance.yahoo.com - June 12 at 9:20 AM
FDA OKs Viela Bios inebilizumab for rare nervous system disorderFDA OKs Viela Bio's inebilizumab for rare nervous system disorder
seekingalpha.com - June 11 at 6:40 PM
Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - June 11 at 6:40 PM
BRIEF-Viela Bio Announces Pricing Of Public Offering Of Common StockBRIEF-Viela Bio Announces Pricing Of Public Offering Of Common Stock
www.reuters.com - May 28 at 8:09 AM
Viela Bio prices equity offering at $47Viela Bio prices equity offering at $47
seekingalpha.com - May 28 at 8:09 AM
Viela Bio readies 3M-share offeringViela Bio readies 3M-share offering
seekingalpha.com - May 26 at 12:25 PM
Viela Bio Announces Proposed Public Offering of Common StockViela Bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - May 26 at 12:25 PM
Some Analysts Just Cut Their Viela Bio, Inc. (NASDAQ:VIE) EstimatesSome Analysts Just Cut Their Viela Bio, Inc. (NASDAQ:VIE) Estimates
finance.yahoo.com - May 15 at 3:59 PM
Viela Bio Inc (VIE) Q1 2020 Earnings Call TranscriptViela Bio Inc (VIE) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 14 at 12:48 PM
Viela Bio, Inc. (VIE) CEO Bing Yao on Q1 2020 Results - Earnings Call TranscriptViela Bio, Inc. (VIE) CEO Bing Yao on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 2:21 AM
BRIEF-Viela Bio Announces Positive Interim Results From Phase 1B Study Of VIB7734BRIEF-Viela Bio Announces Positive Interim Results From Phase 1B Study Of VIB7734
www.reuters.com - May 13 at 9:12 PM
BRIEF-Viela Bio Experienced Minimal Effects On Our Business From Covid-19BRIEF-Viela Bio Experienced Minimal Effects On Our Business From Covid-19
www.reuters.com - May 13 at 9:12 PM
Viela Bio Announces Positive Interim Results from a Phase 1b Study of VIB7734 in Patients with Cutaneous Lupus ErythematosusViela Bio Announces Positive Interim Results from a Phase 1b Study of VIB7734 in Patients with Cutaneous Lupus Erythematosus
finance.yahoo.com - May 13 at 9:12 PM
Viela Bio Reports First Quarter 2020 Financial Results and Program HighlightsViela Bio Reports First Quarter 2020 Financial Results and Program Highlights
finance.yahoo.com - May 13 at 9:12 PM
Viela Bio to Webcast First Quarter 2020 Financial Results and Program Highlights on May 13, 2020Viela Bio to Webcast First Quarter 2020 Financial Results and Program Highlights on May 13, 2020
feeds.benzinga.com - May 6 at 7:11 AM
He led Viela Bio through an IPO. Heres what Bing Yao has his eye on next.He led Viela Bio through an IPO. Here's what Bing Yao has his eye on next.
www.bizjournals.com - March 26 at 7:39 PM
VIELA BIO EPS misses by $5.15, beats on revenueVIELA BIO EPS misses by $5.15, beats on revenue
seekingalpha.com - March 25 at 6:51 PM
Viela Bio, Inc. 2019 Q4 - Results - Earnings Call PresentationViela Bio, Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 25 at 6:51 PM
BRIEF-Viela Bio Inc - For Q4 Of 2019, Co Reported Net Loss Of $11.6 MillionBRIEF-Viela Bio Inc - For Q4 Of 2019, Co Reported Net Loss Of $11.6 Million
www.reuters.com - March 25 at 6:51 PM
Why Viela Bio (VIE) Might Surprise This Earnings SeasonWhy Viela Bio (VIE) Might Surprise This Earnings Season
finance.yahoo.com - March 18 at 1:16 PM
Viela Bio to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on March 25, 2020Viela Bio to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on March 25, 2020
finance.yahoo.com - March 18 at 8:16 AM
Why Earnings Season Could Be Great for Viela Bio (VIE)Why Earnings Season Could Be Great for Viela Bio (VIE)
finance.yahoo.com - March 11 at 11:40 AM
Is a Surprise Coming for Viela Bio (VIE) This Earnings Season?Is a Surprise Coming for Viela Bio (VIE) This Earnings Season?
finance.yahoo.com - February 26 at 1:52 PM
Viela Bio (VIE) Hits Record High, Faces FDA In JuneViela Bio (VIE) Hits Record High, Faces FDA In June
www.nasdaq.com - January 17 at 8:52 AM
Viela Bio (NASDAQ:VIE) Is In A Good Position To Deliver On Growth PlansViela Bio (NASDAQ:VIE) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - January 6 at 4:56 PM
VIE Viela Bio, Inc. Common StockVIE Viela Bio, Inc. Common Stock
www.nasdaq.com - December 18 at 11:58 AM
Viela Bio initiates mid-stage VIB4920 studyViela Bio initiates mid-stage VIB4920 study
seekingalpha.com - December 11 at 9:15 AM
Viela Bio Announces Initiation of Phase 2b Trial of VIB4920 in Sjögren’s SyndromeViela Bio Announces Initiation of Phase 2b Trial of VIB4920 in Sjögren’s Syndrome
finance.yahoo.com - December 11 at 9:15 AM
VIELA BIO EPS misses by $64.33VIELA BIO EPS misses by $64.33
seekingalpha.com - November 14 at 9:43 PM
Viela Bio Reports Third Quarter 2019 Financial Results and Business HighlightsViela Bio Reports Third Quarter 2019 Financial Results and Business Highlights
finance.yahoo.com - November 14 at 4:39 PM
3 “Strong Buy” Biotech Stocks That Recently Went Public3 “Strong Buy” Biotech Stocks That Recently Went Public
finance.yahoo.com - November 12 at 12:26 PM
This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.